F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES for F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Pandemic preparedness; Accutane safety; diabetes issues; Tamiflu; Reimbursement and other issues related to anemia and arthritis drugs. Planning treatment protocols for patiens requireing cancer drugs; issues related to government purchases of pandemic drugs; community relations and outreach to develop and maintain relationships with minority groups and health organizations to promote diabetes awareness. Public policy such as promoting initiatives and strategizing on the most effective approaches to tell the story of Roche's efforts to address and try to resolve health disparities affecting minority communities. Addressed funding for pandemic flu and emergency preparedness. H.R. 1585, The FIT Kids Act, issues addressing childhood obesity; addressed issues pertaining to comprehensive health care reform; comparative effectiveness research. S.1213, Patient-Centered outcomes Research Act of 2009 and S. 3408, H.R.1548, Pathway for Biosimilars Act; and S. 525, Pharmaceutical Market Access & Drug Safety Act of 2009. Track and monitor health care reform including H.R. 1427 and S. 726, Promoting Innovation and Access to Life-Saving Medicince Act General support for Hoffmann-LaRoche products.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARIN GARDNER | Director, Federal Government Affairs |
| ANNA GRIFFIN | Director, Federal Government Affairs |
| KATHERINE MARTIN New | Director, Federal Government Affairs |
| EVAN MORRIS | VP, Federal Government Affairs/Public Policy |
| JAMES SCOTT | Director, Federal Government Affairs |
Budget/Appropriations BUD
H.R. 2346, making supplemental appropriations for the fiscal year ending September 2009 and for other purposes, as it relates to funding for pandemic preparedness. Addressed Tamiflu stockpile for pandemic through Supplemental appropriations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES SCOTT | Director, Federal Government Affairs |
Medicare/Medicaid MMM
Issues related tot he Affordable Health Choices Act, Senate Finance Committee Healthcare reform Legislation and House healthcare Reform legislation. Issues related to Medicare coverage policy for blood glucose monitors and test strips. Issues related to dynamic scoring. Addressed issues related to the Diabetes Access to dynamic scoring.
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BARNETT | Director, Diagnostics |
| KATHLEEN A CLAESSENS | Director, Diagnostics |
| JOYCE IRWIN | Director, Diagnostics |
| BRUCE THOMAS TAYLOR | Director, Diagnostics |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.